A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor recepto

Titel:: A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor recepto
Dokumenttyp:: Meeting Abstract
Autor(en):: Seufferlein, T; Dittrich, C; Riemann, J; Woell, E; Herrmann, T; Lordick, F; Arnold, D; Olchowka, K; Hoehler, T; Schmoll, HJ
Zeitschriftentitel:: J Clin Oncol
Jahr:: 2005
Band / Volume:: 23
Heft / Issue:: 16
Seitenangaben Beitrag:: 281S-281S
Sprache:: eng
Print-ISSN:: 0732-183X
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: